Company: BIAF
Filing Date: 2025-07-25
Form Type: 8-K
Source: 0001641172-25-021012
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-07-25
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item
5.07. Submission of Matters to a Vote of Security Holders.

At
the 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) of bioAffinity Technologies, Inc. (the “ Company”)
held on July 25, 2025, the Company’s stockholders voted on six proposals, each of which is listed below and described in more detail
in the Company’s Definitive Proxy Statement, which was filed with the Securities and Exchange Commission on June 2, 2025.
With respect to each proposal, holders of the Company’s common stock, par value $0.007 per share (the “ Common Stock”),
were entitled to cast one vote per share of Common Stock held as of the close of business on the record date of May 29, 2025 (the “ Record
Date”). On the Record Date there were 28,459,541 shares of the Company’s Common Stock
issued and outstanding and entitled to vote at the 2025 Annual Meeting.

The
following are the final results of voting on each of the proposals presented at the 2025 Annual Meeting:

Proposal
No. 1: Election of Directors.

The
stockholders elected each of the seven director nominees to serve on the Board until the 2026 Annual Meeting of Stockholders and until
such director’s successor has been duly elected and qualified.

  Nominee               Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ─────────────────────────────────────────────────────────────────────────────────────────────
  Maria Zannes          7,693,327            114,549          290,195             6,378,795  
  Steven Girgenti       7,658,376            111,500          328,195             6,378,795  
  Robert Anderson       7,632,198            109,288          356,585             6,378,795  
  Peter Knight          7,630,149            111,266          356,656             6,378,795  
  Gary Rubin            7,426,487            313,718          357,866             6,378,795  
  Roby Joyce, MD        7,629,826            112,674          355,571             6,378,795  
  Jamie Platt, PhD      7,631,076            111,611